Pharmacogenomic Testing to Support Prescribing in Primary Care: a Structured Review of Implementation Models

References

• Pirmohamed M . Personalized pharmacogenomics: predicting efficacy and adverse drug reactions. Annu. Rev. Genomics Hum. Genet.15(1), 349–370 (2014).
   PubMedGoogle Scholar
• Swen JJ , HuizingaTW , GelderblomHet al. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med.4(8), e209 (2007).
   PubMed Web of Science ®Google Scholar
• Pirmohamed M , BurnsideG , ErikssonNet al. A randomized trial of genotype-guided dosing of warfarin. N. Engl. J. Med.369(24), 2294–2303 (2013).
   PubMed Web of Science ®Google Scholar
• Turner RM , PirmohamedM. Statin-related myotoxicity: a comprehensive review of pharmacokinetic, pharmacogenomic and muscle components. J. Clin. Med.9(1), 22 (2019).
   PubMed Web of Science ®Google Scholar
• Swen J , WiltingI , de GoedeAet al. Pharmacogenetics: from bench to byte. Clin. Pharmacol. Ther.83(5), 781–787 (2008).
   PubMed Web of Science ®Google Scholar
• Relling MV , KleinTE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin. Pharmacol. Ther.89(3), 464–467 (2011).
   PubMed Web of Science ®Google Scholar
• Guo C , XieX , LiJet al. Pharmacogenomics guidelines: current status and future development. Clin. Exp. Pharmacol. Physiol.46(8), 689–693 (2019).
   PubMed Web of Science ®Google Scholar
• Alfirevic A , PirmohamedM. Genomics of adverse drug reactions. Trends Pharmacol. Sci.38(1), 100–109 (2017).
   PubMed Web of Science ®Google Scholar
• Health Survey for England, 2016 – NHS Digital. https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/health-survey-for-england-2016
   Google Scholar
• NHS England – Primary care. https://www.england.nhs.uk/five-year-forward-view/next-steps-on-the-nhs-five-year-forward-view/primary-care/
   Google Scholar
• Prescriptions Dispensed in the Community – Statistics for England, 2007–2017 – NHS Digital. https://digital.nhs.uk/data-and-information/publications/statistical/prescriptions-dispensed-in-the-community/prescriptions-dispensed-in-the-community-england---2007---2017
   Google Scholar
• The King’s Fund . Polypharmacy and medicines optimization: making it safe and sound (2013). https://www.kingsfund.org.uk/publications/polypharmacy-and-medicines-optimisation
   Google Scholar
• Kimpton JE , CareyIM , ThreapletonCJDet al. Longitudinal exposure of English primary care patients to pharmacogenomic drugs: an analysis to inform design of pre-emptive pharmacogenomic testing. Br. J. Clin. Pharmacol.85(12), 2734–2746 (2019).
   PubMed Web of Science ®Google Scholar
• Youssef E , KirkdaleCL , WrightDJ , GuchelaarH , ThornleyT. Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK. Br. J. Clin. Pharmacol.87( 7), 2907–2925 (2021).
   PubMed Web of Science ®Google Scholar
• Health economics of pharmacogenomics – Professor Dyfrig Hughes. http://www.uk-pgx-stratmed.co.uk/index.php/health-economics-of-pharmacogenomics-professor-dyfrig-hughes.html
   Google Scholar
• Plumpton CO , PirmohamedM , HughesDA. Cost–effectiveness of panel tests for multiple pharmacogenes associated with adverse drug reactions: an evaluation framework. Clin. Pharmacol. Ther.105(6), 1429–1438 (2019).
   PubMed Web of Science ®Google Scholar
• Orlando LA , SperberNR , VoilsCet al. Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network’s Common Measures Working Group. Genet. Med.20(6), 655–663 (2018).
   PubMed Web of Science ®Google Scholar
• Kozlowska O , LumbA , TanGD , ReaR. Barriers and facilitators to integrating primary and specialist healthcare in the United Kingdom: a narrative literature review. Future Healthc. J.5(1), 64–80 (2018).
   PubMedGoogle Scholar
• PRISMA-P Group , MoherD , ShamseerLet al.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev.4(1), 1 (2015).
   PubMedGoogle Scholar
• Dressler LG , BellGC , AbernathyPM , RuchK , DenslowS. Implementing pharmacogenetic testing in rural primary care practices: a pilot feasibility study. Pharmacogenomics20(6), 433–446 (2019).
   PubMed Web of Science ®Google Scholar
• Dressler LG , BellGC , RuchKD , RetamalJD , KrugPB , PaulusRA. Implementing a personalized medicine program in a community health system. Pharmacogenomics19(17), 1345–1356 (2018).
   PubMed Web of Science ®Google Scholar
• Dunnenberger HM , BiszewskiM , BellGCet al. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system. Am. J. Health. Syst. Pharm.73(23), 1956–1966 (2016).
   PubMed Web of Science ®Google Scholar
• Lemke AA , HuttenSelkirk CG , GlaserNSet al. Primary care physician experiences with integrated pharmacogenomic testing in a community health system. Pers. Med.14(5), 389–400 (2017).
   PubMed Web of Science ®Google Scholar
• Lemke AA , HulickPJ , WakeDTet al. Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Pharmacogenomics19(4), 321–331 (2018).
   PubMed Web of Science ®Google Scholar
• Schwartz EJ , TurgeonJ , PatelJet al. Implementation of a standardized medication therapy management plus approach within primary care. J. Am. Board Fam. Med.30(6), 701–714 (2017).
   PubMed Web of Science ®Google Scholar
• Haga SB , AllenLaPointe NM , ChoAet al. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting. Pharmacogenomics15(13), 1677–1686 (2014).
   PubMed Web of Science ®Google Scholar
• Haga SB , MillsR , MoaddebJ , AllenLaPointe N , ChoA , GinsburgGS. Primary care providers’ use of pharmacist support for delivery of pharmacogenetic testing. Pharmacogenomics18(4), 359–367 (2017).
   PubMed Web of Science ®Google Scholar
• Dawes M , AloiseMN , AngJSet al. Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study. CMAJ Open4(3), E528–E534 (2016).
   PubMedGoogle Scholar
• Papastergiou J , ToliosP , LiW , LiJ. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study. J. Am. Pharm. Assoc.57(5), 624–629 (2017).
   Google Scholar
• Bank PCD , SwenJJ , SchaapRD , KlootwijkDB. Baak – Pablo R, GuchelaarH-J. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care. Eur. J. Hum. Genet.27(10), 1532–1541 (2019).
   PubMed Web of Science ®Google Scholar
• van der Wouden CH , BankPCD , ÖzokcuK , SwenJJ , GuchelaarH-J. Pharmacist-initiated pre-emptive pharmacogenetic panel testing with clinical decision support in primary care: record of PGx results and real-world impact. Genes10(6), 416 (2019).
   PubMed Web of Science ®Google Scholar
• van der Wouden CH , PaasmanE , TeichertM , CroneMR , GuchelaarH-J , SwenJJ. Assessing the implementation of pharmacogenomic panel-testing in primary care in the netherlands utilizing a theoretical framework. J. Clin. Med.9(3), 814 (2020).
   PubMed Web of Science ®Google Scholar
• Hill-Taylor B , SketrisI , HaydenJ , ByrneS , O’SullivanD , ChristieR. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J. Clin. Pharm. Ther.38(5), 360–372 (2013).
   PubMed Web of Science ®Google Scholar
• Callard A , NewmanW , PayneK. Delivering a pharmacogenetic service: is there a role for genetic counselors?J. Genet. Couns.21(4), 527–535 (2012).
   PubMed Web of Science ®Google Scholar
• Facilitating genomic testing: a competency framework – Genomics Education Programme. https://www.genomicseducation.hee.nhs.uk/consent-a-competency-framework/
   Google Scholar
• Fargher EA , EddyC , NewmanWet al. Patients’ and healthcare professionals’ views on pharmacogenetic testing and its future delivery in the NHS. Pharmacogenomics8(11), 1511–1519 (2007).
   PubMed Web of Science ®Google Scholar
• Relling MV , AltmanRB , GoetzMP , EvansWE. Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism. Lancet Oncol.11(6), 507–509 (2010).
   PubMed Web of Science ®Google Scholar
• Pirmohamed M , HughesDA. Pharmacogenetic tests: the need for a level playing field. Nat. Rev. Drug Discov.12(1), 3–4 (2013).
   PubMed Web of Science ®Google Scholar
• Mills R , VooraD , PeyserB , HagaS. Delivering pharmacogenetic testing in a primary care setting. Pharmacogenomics Pers. Med.6, 105–112 (2013).
   PubMedGoogle Scholar
• Weitzel KW , DuongBQ , ArwoodMJet al. A stepwise approach to implementing pharmacogenetic testing in the primary care setting. Pharmacogenomics20(15), 1103–1112 (2019).
   PubMed Web of Science ®Google Scholar
• Robertson JA . Consent and privacy in pharmacogenetic testing. Nat. Genet.28(3), 207–209 (2001).
   PubMed Web of Science ®Google Scholar
• Clyman JC , NazirF , TarolliS , BlackE , LombardiRQ , HigginsJJ. The impact of a genetics education program on physicians’ knowledge and genetic counseling referral patterns. Med. Teach.29(6), e143–e150 (2007).
   PubMed Web of Science ®Google Scholar
• Houwink EJ , van TeeffelenSR , MuijtjensAMet al. Sustained effects of online genetics education: a randomized controlled trial on oncogenetics. Eur. J. Hum. Genet.22(3), 310–316 (2014).
   PubMed Web of Science ®Google Scholar
• Evans WRH , TranterJ , RafiI , HaywardJ , QureshiN. How genomic information is accessed in clinical practice: an electronic survey of UK general practitioners. J. Community Genet.11(3), 377–386 (2020).
   PubMed Web of Science ®Google Scholar
• Mathers J , GreenfieldS , MetcalfeA , ColeT , FlanaganS , WilsonS. Family history in primary care: understanding GPs’ resistance to clinical genetics – qualitative study. Br. J. Gen. Pract.60(574), e221–e230 (2010).
   PubMed Web of Science ®Google Scholar
• Qureshi N . Continuous medical education approaches for clinical genetics: a postal survey of general practitioners. J. Med. Genet.39(11), 69e–669 (2002).
   Google Scholar
• Mikat-Stevens NA , LarsonIA , TariniBA. Primary-care providers’ perceived barriers to integration of genetics services: a systematic review of the literature. Genet. Med.17(3), 169–176 (2015).
   PubMed Web of Science ®Google Scholar
• Primary Care Genetics Curriculum – primary care genetics. https://www.primarycaregenetics.org/?page_id=399&lang=en
   Google Scholar
• Clinical topic guides. https://www.rcgp.org.uk/training-exams/training/gp-curriculum-new/clinical-topic-guides.aspx
   Google Scholar
• Interim Foundation Pharmacist curriculum. https://www.rpharms.com/development/credentialing/foundation/interim-foundation-pharmacist-curriculum
   Google Scholar
• Miech EJ , RattrayNA , FlanaganME , DamschroderL , SchmidAA , DamushTM. Inside help: an integrative review of champions in healthcare-related implementation. SAGE Open Med.6, 2050312118773261 (2018).
   Google Scholar
• Martin GP , WeaverS , CurrieG , FinnR , McDonaldR. Innovation sustainability in challenging health-care contexts: embedding clinically led change in routine practice. Health Serv. Manage. Res.25(4), 190–199 (2012).
   PubMedGoogle Scholar
• Slade I , BurtonH. Preparing clinicians for genomic medicine: table 1. Postgrad. Med. J.92(1089), 369–371 (2016).
   PubMed Web of Science ®Google Scholar
• Haidar C-E . Pharmacist’s Role in Clinical Pharmacogenomics. American Journal of Health-System Pharmacy72(7), 579–581 (2015).
   PubMedGoogle Scholar
• Consultant Pharmacist Credentialing. https://www.rpharms.com/development/credentialing/consultant/consultant-pharmacist-credentialing#how
   Google Scholar
• Education Precision Prescribing. https://test.genxys.com/content/education-materials/
   Google Scholar
• Wright D , BhattD. Targeted medicines: how pharmacists can lead a pharmacogenomics revolution. Clin. Pharm.10(6), 162–164 (2018).
   Google Scholar
• Avery AJ , RodgersS , CantrillJAet al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost–effectiveness analysis. Lancet379(9823), 1310–1319 (2012).
   PubMed Web of Science ®Google Scholar
• Medicines optimization: the safe and effective use of medicines to enable the best possible outcomes. https://www.nice.org.uk/guidance/ng5
   Google Scholar
• Royal S . Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual. Saf. Health Care15(1), 23–31 (2006).
   PubMedGoogle Scholar
• Hicks JK , DunnenbergerHM , GumpperKF , HaidarCE , HoffmanJM. Integrating pharmacogenomics into electronic health records with clinical decision support. Am. J. Health. Syst. Pharm.73(23), 1967–1976 (2016).
   PubMed Web of Science ®Google Scholar
• van der Wouden CH , CarereDA , Maitland-vander Zee AHet al. Consumer perceptions of interactions with primary care providers after direct-to-consumer personal genomic testing. Ann. Intern. Med.164(8), 513 (2016).
   PubMed Web of Science ®Google Scholar
• Darst BF , MadlenskyL , SchorkNJ , TopolEJ , BlossCS. Characteristics of genomic test consumers who spontaneously share results with their health care provider. Health Commun.29(1), 105–108 (2014).
   PubMed Web of Science ®Google Scholar
• Blagec K , RomagnoliKM , BoyceRD , SamwaldM. Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study. PeerJ4, e1671 (2016).
   PubMed Web of Science ®Google Scholar
• Haga SB , MoaddebJ. Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenet Genomics24(3), 139–145 (2014).
   PubMed Web of Science ®Google Scholar
• Relling MV , EvansWE. Pharmacogenomics in the clinic. Nature526(7573), 343–350 (2015).
   PubMed Web of Science ®Google Scholar
• Dunnenberger HM , CrewsKR , HoffmanJMet al. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu. Rev. Pharmacol. Toxicol.55(1), 89–106 (2015).
   PubMedGoogle Scholar
• Bank P , CaudleK , SwenJet al. Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group. Clin. Pharmacol. Ther.103(4), 599–618 (2018).
   PubMed Web of Science ®Google Scholar
• Hinderer M , BoekerM , WagnerSAet al. Integrating clinical decision support systems for pharmacogenomic testing into clinical routine – a scoping review of designs of user-system interactions in recent system development. BMC Med. Inform. Decis. Mak.17(1), 81 (2017).
   PubMedGoogle Scholar
• Bell GC , CrewsKR , WilkinsonMRet al. Development and use of active clinical decision support for preemptive pharmacogenomics. J. Am. Med. Inform. Assoc.21(e1), e93–e99 (2014).
   PubMed Web of Science ®Google Scholar
• Weingart SN , TothM , SandsDZ , AronsonMD , DavisRB , PhillipsRS. Physicians’ decisions to override computerized drug alerts in primary care. Arch. Intern. Med.163(21), 2625 (2003).
   PubMedGoogle Scholar
• Ranji SR , RennkeS , WachterRM. Computerised provider order entry combined with clinical decision support systems to improve medication safety: a narrative review. BMJ Qual. Saf.23(9), 773–780 (2014).
   PubMed Web of Science ®Google Scholar
• Dalleur O , FeronJ-M , SpinewineA. Views of general practitioners on the use of STOPP&START in primary care: a qualitative study. Acta Clin. Belg.69(4), 251–261 (2014).
   PubMed Web of Science ®Google Scholar
• Jeffries M , PhippsDL , HowardRL , AveryAJ , RodgersS , AshcroftDM. Understanding the implementation and adoption of a technological intervention to improve medication safety in primary care: a realist evaluation. BMC Health Serv. Res.17(1), 196 (2017).
   PubMedGoogle Scholar
• CMAJ . The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. https://www.cmaj.ca/content/169/6/549.abstract
   Google Scholar
• Huibers CJA , SalleveltBTGM , de GrootDAet al. Conversion of STOPP/START version 2 into coded algorithms for software implementation: a multidisciplinary consensus procedure. Int. J. Med. Inf.125, 110–117 (2019).
   PubMed Web of Science ®Google Scholar
• de Groot DA , de VriesM , JolingKJet al. Specifying ICD9, ICPC and ATC codes for the STOPP/START criteria: a multidisciplinary consensus panel. Age. Ageing43(6), 773–778 (2014).
   PubMed Web of Science ®Google Scholar
• Rafi I , CrinsonI , DawesM , RafiD , PirmohamedM , WalterFM. The implementation of pharmacogenomics into UK general practice: a qualitative study exploring barriers, challenges and opportunities. J. Community Genet.11(3), 269–277 (2020).
   PubMed Web of Science ®Google Scholar